Network News

The US magazine “Newsweek” has once again named Heidelberg University Hospital (UKHD) one of the best hospitals in the world. In the “World’s Best Hospitals 2025” ranking, which is compiled by “Newsweek” in collaboration with the statistics and data platform “Statista”, the UKHD ranks 14th out of 2,400 hospitals worldwide. In Germany, the UKHD is […]

The Bayer Foundation’s Early Excellence in Science Award 2024 in the category of Data Science goes to Ivana Winkler of the German Cancer Research Center (DKFZ). Winkler’s work uncovered the unexpected effect of female reproductive capacity: the constantly recurring remodeling of the organs of the female reproductive tract during the sexual cycle leads to fibrosis […]

This year, the most highly endowed award in the neurosciences and neuromedical research honors pioneering work on the interactions between the nervous system and brain tumors: Neurologist Frank Winkler, who conducts research at the University of Heidelberg and at the German Cancer Research Center (DKFZ) and treats patients with brain tumors at Heidelberg University Hospital, […]

Nicht nur in der Versorgung, sondern auch in der Wirtschaft fehlen Fachkräfte in der Gesundheitsindustrie. Bei einer Podiumsdiskussion am 11. März 2025, die am Vortag der Jobmesse T5 in Stuttgart stattfindet, will das Forum Gesundheitsstandort Baden-Württemberg zu den Themen Fachkräfte gewinnen, Wirtschaft stärken und Gesundheit fördern diskutieren. Ob Medizintechnik, Pharma oder Biotechnologie – Baden-Württemberg ist […]

Approval based on positive results from Phase III ATTRibute-CM study / Beyonttra™ is a near-complete (≥90%) stabilizer of transthyretin (TTR) minimizing amyloid formation / Phase III ATTRibute-CM study with Beyonttra™ has shown clear benefits on cardiovascular endpoints already starting as early as 3 months after treatment initiation Berlin, February 11, 2025 – The European Commission has […]

International project consortium is coordinated at Heidelberg University Targeted molecular interventions in the replication cycle and the immune recognition of viruses are intended to prevent viral entry into cells and virus replication. That is the goal of an international research project in which scientists work on new approaches to combating highly dangerous viral diseases such […]

February 19, 2025 Basel, Switzerland, 19 February 2025 – Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), announced today the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech for the production of catumaxomab for Commercial Supply. Catumaxomab is a first-in-class, trifunctional bispecific monoclonal antibody designed for the intraperitoneal treatment of […]

Handelsblatt | 07.02.2025 —Innovation — Deutschlands wichtigste Wette auf die Zukunft Handelsblatt Insight Biotechnologie zählt zu den vielversprechendsten Wirtschaftsfeldern. Die Bundesrepublik zeigt dabei laut einer neuen Studie überraschende Stärken. Experten sehen allerdings Probleme, die dringend gelöst werden müssen. Der deutsche Mikrobiologe Robert Koch findet 1882 den Erreger für die Krankheit Tuberkulose. 1895: Wilhelm Conrad Röntgen entdeckt in […]

BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados, a new research initiative focused on better treatment of cardiometabolic diseases in individuals of African descent. Heidelberg, Germany / Bridgetown, Barbados – February 20, 2025. BioMed X Institute is proud to announce a partnership with the […]